| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 12 | 2023 | 771 | 1.950 |
Why?
|
| Precursor Cells, B-Lymphoid | 6 | 2023 | 27 | 1.760 |
Why?
|
| Cell Differentiation | 11 | 2023 | 1666 | 1.060 |
Why?
|
| Receptors, Antigen, B-Cell | 5 | 2022 | 120 | 1.030 |
Why?
|
| Lymphopoiesis | 5 | 2019 | 48 | 0.870 |
Why?
|
| Immunoglobulins | 2 | 2015 | 144 | 0.790 |
Why?
|
| Chromatin | 4 | 2023 | 446 | 0.760 |
Why?
|
| Epigenesis, Genetic | 4 | 2024 | 554 | 0.740 |
Why?
|
| Recombination, Genetic | 4 | 2022 | 444 | 0.640 |
Why?
|
| Carrier Proteins | 2 | 2024 | 683 | 0.630 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2019 | 94 | 0.610 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 49 | 0.610 |
Why?
|
| Agammaglobulinemia | 1 | 2018 | 21 | 0.580 |
Why?
|
| Signal Transduction | 13 | 2023 | 3581 | 0.580 |
Why?
|
| STAT5 Transcription Factor | 4 | 2019 | 45 | 0.500 |
Why?
|
| Histone Acetyltransferases | 1 | 2015 | 45 | 0.460 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2008 | 432 | 0.430 |
Why?
|
| Mice | 23 | 2024 | 12538 | 0.420 |
Why?
|
| Cell Cycle | 4 | 2012 | 516 | 0.420 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 750 | 0.410 |
Why?
|
| Mice, Knockout | 12 | 2020 | 2161 | 0.400 |
Why?
|
| Animals | 32 | 2024 | 28914 | 0.400 |
Why?
|
| Germinal Center | 3 | 2023 | 65 | 0.400 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2020 | 91 | 0.340 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 165 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 11 | 2024 | 3489 | 0.320 |
Why?
|
| T-Lymphocytes | 5 | 2017 | 1316 | 0.310 |
Why?
|
| Receptors, Interleukin-7 | 4 | 2019 | 30 | 0.310 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2020 | 69 | 0.310 |
Why?
|
| Gene Expression Regulation | 6 | 2023 | 2059 | 0.310 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2008 | 14 | 0.300 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2008 | 16 | 0.290 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2009 | 204 | 0.290 |
Why?
|
| ras Proteins | 1 | 2009 | 134 | 0.290 |
Why?
|
| Pre-B Cell Receptors | 2 | 2019 | 8 | 0.260 |
Why?
|
| Mice, Inbred BALB C | 2 | 2024 | 1124 | 0.250 |
Why?
|
| Interleukin-7 | 3 | 2020 | 47 | 0.250 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2018 | 110 | 0.230 |
Why?
|
| Genes, bcl-2 | 1 | 2005 | 15 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 684 | 0.230 |
Why?
|
| Proteomics | 2 | 2024 | 268 | 0.220 |
Why?
|
| Cell Proliferation | 5 | 2023 | 1754 | 0.220 |
Why?
|
| alpha-Synuclein | 1 | 2024 | 24 | 0.220 |
Why?
|
| Cyclin D3 | 4 | 2013 | 21 | 0.220 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 2 | 2017 | 41 | 0.220 |
Why?
|
| Thymus Gland | 4 | 2009 | 206 | 0.220 |
Why?
|
| Lymphocytes | 2 | 2017 | 489 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2018 | 152 | 0.210 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2003 | 18 | 0.210 |
Why?
|
| Membrane Proteins | 2 | 2008 | 1276 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 207 | 0.210 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 89 | 0.190 |
Why?
|
| Skin Transplantation | 1 | 2024 | 193 | 0.190 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 1533 | 0.190 |
Why?
|
| Parkinson Disease | 1 | 2024 | 178 | 0.190 |
Why?
|
| Muscle, Smooth | 1 | 2003 | 358 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2009 | 113 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 1 | 2024 | 515 | 0.180 |
Why?
|
| Pulmonary Artery | 1 | 2003 | 341 | 0.180 |
Why?
|
| Down-Regulation | 2 | 2015 | 526 | 0.180 |
Why?
|
| Antigens, CD1 | 2 | 1998 | 37 | 0.170 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 412 | 0.170 |
Why?
|
| Cellular Microenvironment | 1 | 2020 | 30 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 667 | 0.160 |
Why?
|
| Protein Binding | 4 | 2024 | 1560 | 0.160 |
Why?
|
| Chemokine CXCL12 | 1 | 2019 | 38 | 0.150 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2019 | 42 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2019 | 2940 | 0.150 |
Why?
|
| Cell Survival | 5 | 2009 | 1030 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2018 | 305 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2011 | 182 | 0.150 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 77 | 0.150 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 83 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2012 | 623 | 0.140 |
Why?
|
| CD79 Antigens | 1 | 2017 | 17 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 13 | 0.140 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2017 | 15 | 0.140 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2017 | 18 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 212 | 0.130 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 60 | 0.130 |
Why?
|
| Ubiquitination | 1 | 2017 | 81 | 0.130 |
Why?
|
| Receptors, Antigen | 1 | 2017 | 13 | 0.130 |
Why?
|
| Endosomes | 1 | 2017 | 86 | 0.130 |
Why?
|
| Natural Killer T-Cells | 1 | 2017 | 46 | 0.130 |
Why?
|
| Adenosine | 1 | 2020 | 278 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 259 | 0.130 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 151 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 563 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2015 | 740 | 0.130 |
Why?
|
| Base Sequence | 3 | 2020 | 2344 | 0.120 |
Why?
|
| RNA | 1 | 2020 | 605 | 0.120 |
Why?
|
| Methylation | 2 | 2020 | 295 | 0.120 |
Why?
|
| Flow Cytometry | 3 | 2012 | 727 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 321 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2010 | 446 | 0.120 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 1995 | 2 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2015 | 88 | 0.110 |
Why?
|
| Pregnancy Proteins | 1 | 1995 | 37 | 0.110 |
Why?
|
| Apoptosis | 2 | 2015 | 1760 | 0.110 |
Why?
|
| DNA Damage | 2 | 2023 | 392 | 0.110 |
Why?
|
| COS Cells | 2 | 2011 | 168 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 1191 | 0.100 |
Why?
|
| Fetus | 1 | 1995 | 239 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2006 | 327 | 0.100 |
Why?
|
| Placenta | 1 | 1995 | 191 | 0.100 |
Why?
|
| Immunoblotting | 2 | 2012 | 280 | 0.100 |
Why?
|
| Binding Sites | 2 | 2015 | 1167 | 0.100 |
Why?
|
| NF-kappa B | 2 | 2006 | 469 | 0.100 |
Why?
|
| Binding, Competitive | 1 | 2011 | 147 | 0.090 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2011 | 32 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 563 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 2 | 2012 | 180 | 0.090 |
Why?
|
| Humans | 11 | 2024 | 96093 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2011 | 392 | 0.080 |
Why?
|
| Male | 5 | 2024 | 45870 | 0.080 |
Why?
|
| Ikaros Transcription Factor | 1 | 2010 | 25 | 0.080 |
Why?
|
| Ammonium Sulfate | 2 | 2003 | 3 | 0.080 |
Why?
|
| Chromatography, Ion Exchange | 2 | 2003 | 33 | 0.080 |
Why?
|
| Cell Line | 4 | 2015 | 2533 | 0.080 |
Why?
|
| Chromatography, Gel | 2 | 2003 | 104 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 3040 | 0.080 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2009 | 23 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 75 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2009 | 43 | 0.080 |
Why?
|
| Cyclins | 1 | 2009 | 80 | 0.080 |
Why?
|
| Histones | 1 | 2011 | 363 | 0.080 |
Why?
|
| Receptor, Notch1 | 2 | 2006 | 101 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 124 | 0.070 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2008 | 21 | 0.070 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2008 | 20 | 0.070 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2008 | 25 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2009 | 181 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 80 | 0.070 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2006 | 16 | 0.070 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 286 | 0.070 |
Why?
|
| Cell Death | 1 | 2008 | 264 | 0.070 |
Why?
|
| beta Catenin | 1 | 2009 | 266 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 897 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 701 | 0.070 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2020 | 129 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 367 | 0.060 |
Why?
|
| Leukemia, T-Cell | 1 | 2006 | 17 | 0.060 |
Why?
|
| Child | 1 | 2018 | 7626 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 2090 | 0.060 |
Why?
|
| Lymphocyte Activation | 3 | 2019 | 810 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 465 | 0.060 |
Why?
|
| Adolescent | 1 | 2018 | 9896 | 0.060 |
Why?
|
| Type C Phospholipases | 1 | 2005 | 27 | 0.060 |
Why?
|
| Bone Marrow | 2 | 2019 | 458 | 0.060 |
Why?
|
| Caspase Inhibitors | 1 | 2005 | 32 | 0.060 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2005 | 40 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2005 | 164 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 632 | 0.050 |
Why?
|
| Chromatography | 1 | 2003 | 28 | 0.050 |
Why?
|
| Liver | 2 | 2019 | 1238 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2005 | 267 | 0.050 |
Why?
|
| Concanavalin A | 1 | 2003 | 50 | 0.050 |
Why?
|
| Fibrinolysin | 1 | 2003 | 26 | 0.050 |
Why?
|
| Trypsin | 1 | 2003 | 95 | 0.050 |
Why?
|
| Chromatography, Affinity | 1 | 2003 | 84 | 0.050 |
Why?
|
| Collagenases | 1 | 2003 | 42 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 270 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2003 | 84 | 0.050 |
Why?
|
| Cytosol | 1 | 2003 | 198 | 0.050 |
Why?
|
| Cellulose | 1 | 2003 | 59 | 0.050 |
Why?
|
| Cattle | 1 | 2003 | 386 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2022 | 1730 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 141 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2024 | 188 | 0.050 |
Why?
|
| Heparin | 1 | 2003 | 186 | 0.050 |
Why?
|
| Plasma Cells | 1 | 2023 | 88 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 639 | 0.050 |
Why?
|
| Transplantation Tolerance | 1 | 2024 | 143 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 453 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2003 | 797 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2015 | 1267 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 750 | 0.050 |
Why?
|
| Female | 3 | 2024 | 50030 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 261 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2003 | 777 | 0.040 |
Why?
|
| Cell Size | 1 | 2020 | 71 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2024 | 1375 | 0.040 |
Why?
|
| Immunoglobulin Light Chains, Surrogate | 1 | 2019 | 4 | 0.040 |
Why?
|
| N-Formylmethionine | 1 | 1999 | 5 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 34 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 326 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2020 | 303 | 0.040 |
Why?
|
| Proteome | 1 | 2020 | 156 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2020 | 213 | 0.040 |
Why?
|
| Adult | 1 | 2018 | 28716 | 0.040 |
Why?
|
| Radioimmunoassay | 1 | 1998 | 150 | 0.040 |
Why?
|
| Cell Compartmentation | 1 | 1998 | 70 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1999 | 209 | 0.040 |
Why?
|
| Oligopeptides | 1 | 1999 | 195 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2024 | 1126 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 1998 | 128 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 399 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2017 | 16 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1998 | 297 | 0.030 |
Why?
|
| Epitopes | 1 | 1998 | 258 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 305 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 1157 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 648 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 74 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2017 | 95 | 0.030 |
Why?
|
| Spleen | 1 | 1998 | 439 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 1998 | 279 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2017 | 173 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2017 | 109 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 101 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 98 | 0.030 |
Why?
|
| Endocytosis | 1 | 2017 | 186 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 164 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1997 | 136 | 0.030 |
Why?
|
| Pregnancy | 1 | 2024 | 3240 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 107 | 0.030 |
Why?
|
| Mutation | 2 | 2024 | 4374 | 0.030 |
Why?
|
| Computational Biology | 1 | 2020 | 584 | 0.030 |
Why?
|
| Antigens | 1 | 1997 | 231 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2017 | 324 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 180 | 0.030 |
Why?
|
| V(D)J Recombination | 1 | 2015 | 12 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 294 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1999 | 1429 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2015 | 64 | 0.030 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1995 | 4 | 0.030 |
Why?
|
| Chemical Precipitation | 1 | 1995 | 18 | 0.030 |
Why?
|
| Proton-Translocating ATPases | 1 | 1995 | 24 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1997 | 290 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1995 | 333 | 0.030 |
Why?
|
| Time Factors | 1 | 2003 | 5585 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 263 | 0.030 |
Why?
|
| Macrophages | 1 | 1998 | 626 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 769 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2090 | 0.030 |
Why?
|
| Cyclin D2 | 1 | 2013 | 18 | 0.030 |
Why?
|
| Cytokines | 1 | 1998 | 872 | 0.030 |
Why?
|
| Genomics | 1 | 2020 | 855 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 464 | 0.030 |
Why?
|
| Cell Division | 1 | 1995 | 705 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 1932 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 179 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 284 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 98 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 33 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 29 | 0.020 |
Why?
|
| PAX5 Transcription Factor | 1 | 2012 | 33 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 1995 | 385 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 548 | 0.020 |
Why?
|
| Proteins | 1 | 1997 | 816 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2010 | 68 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2009 | 80 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 908 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 2006 | 15 | 0.020 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2006 | 13 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 992 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2006 | 84 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2006 | 82 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2006 | 55 | 0.020 |
Why?
|
| Bortezomib | 1 | 2006 | 82 | 0.020 |
Why?
|
| Smoothened Receptor | 1 | 2006 | 6 | 0.020 |
Why?
|
| Veratrum Alkaloids | 1 | 2006 | 10 | 0.020 |
Why?
|
| Pyrazines | 1 | 2006 | 94 | 0.020 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2006 | 17 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2006 | 84 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 313 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 2006 | 107 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2006 | 394 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 164 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 930 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 465 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2006 | 1546 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 1645 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 2777 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1999 | 36 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1999 | 58 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1999 | 142 | 0.010 |
Why?
|
| Cricetinae | 1 | 1999 | 542 | 0.010 |
Why?
|
| Biological Transport | 1 | 1999 | 412 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 1999 | 229 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 1997 | 4 | 0.010 |
Why?
|
| Hemocyanins | 1 | 1997 | 8 | 0.010 |
Why?
|
| Antigens, Ly | 1 | 1997 | 37 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1997 | 107 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 1997 | 89 | 0.010 |
Why?
|
| Kinetics | 1 | 1999 | 1562 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1997 | 152 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1999 | 695 | 0.010 |
Why?
|
| Th2 Cells | 1 | 1997 | 151 | 0.010 |
Why?
|